Magnetic Resonance Imaging Market Size, Share, Growth, and Industry Analysis, By Type (0.2T , 1.5 T, 3.0 T) By Application (Neurosurgery surgery, Spinal surgery, Orthopedic surgery, Other) and Regional Insights and Forecast to 2034

•   
•   
  

  Request a Free sample to learn more about this report

    

MAGNETIC RESONANCE IMAGING MARKET OVERVIEW

The global magnetic resonance imaging market size was USD 7.97 billion in 2025 and is projected to reach USD 13.68 billion by 2034, exhibiting a CAGR of 6.2% during the forecast period.

A non-invasive medical imaging device utilizing both powerful magnetic fields and radiofrequency pulses to produce detailed localized images of soft tissues, organs and the central nervous system, magnetic resonance imaging (MRI) finds extensive application in neurology, oncology, orthopedics, cardiology and musculoskeletal diagnostics due to its better soft-tissue contrast and availability of non-ionizing radiation. The MRI market is made up of hardware (scanner systems, field strengths), software (image reconstruction, analysis and workflow solutions), accessories (patients handling systems, coils, etc.), and services (installation, maintenance, training, upgrades, etc.). The last ten years MRI sellers have worked on the optimization of image quality, scan times, expanding the capability of images (functional MRI, MR spectroscopy, MR guided interventions), and the combination of a sophisticated computer program and AI in better throughput and diagnostic accuracy. The increasing market intensity and growth is spurred by increasing cases of chronic diseases and neurological disorders, ageing populations, and need to invest more in healthcare infrastructure in emerging markets and as well as greater pressures on patients to feel comfortable during imaging (wider bores, shorter scans). Simultaneously, cost of the system, infrastructure needs (shielded rooms, cooling, site preparation), other types of the imaging effect competition on some of the indications temper adoption. Improvements like lower-field portable, helium-free magnetic, cloud/AI-enabling workflows are transforming hospital and imaging center of choices when acquiring new purchases and the overall cost of ownership. We have an existent competitive market characterized by global OEMs concentration and the existence of software innovators and service providers with an opportunity to acquire value in the imaging ecosystem.

COVID-19 IMPACT

Magnetic Resonance Imaging Market Had a Negative Effect Due to Supply Chain Disruption During COVID-19 Pandemic

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic also sharpened in the short term both the use of magnetic resonance imaging market share and its sale to the activity elective and regular imaging procedures; most of the imaging departments tightened their activities and volumes to adopt infection control and social-distancing practices. In 2020 and part of 2021, disruptions to supply chains and temporary shutdown of factories caused delivery of new scanners and parts to be pushed back and capital expenditure on equipment by some suppliers was put on hold by financial uncertainty. Moreover, the requirements of infection-control added to the per-scan turnover time (cleaning and air-exchange) which further decreased the throughput and revenue of the imaging centers, leading some locations to postpone upgrades or purchasing projects. The pandemic also beefed up the need in remote workflow, teleradiology, and software treatments, making a few of these vendor markets base their attention not on equipment but on providers and focuses on unusual markets based on the cloud. Even after demand revived, with the resumption of elective procedures and sizeable backlogs of imaging patients, the pandemic brought into focus supply chain weaknesses and demand the need to incorporate the demand to provide and services models flexibly, as well as to provide remote support, inspiring new contracting and maintenance practices, among the providers and manufactures of such procedures. Altogether, the effects of the wider consequences of COVID-related triggered growth tightening in the short-term but also triggered swift digital transformation and new models of service that are shaping the recovery of the MRI market and its future makeup.

LATEST TRENDS

AI-Accelerated MRI Workflows and Quantitative Imaging Are Becoming Mainstream Drives Market Growth

One of the trends that are prevailing in MRI and are maturing very fast is the adoption of advanced artificial intelligence in image acquisition as well as in post-processing procedures of MRI to shorten scan time, enhance image quality, and provide quantitative biomarkers. Since vendors cost more, they manufacture scanners and software suites, which incorporate AI-powered reconstruction and denoising algorithms to reduce scan times (which in many cases are much shorter) without compromising the quality of diagnostic images (and usually improving it), facilitating increased throughput and even patient comfort. Three ways and strategies Cloud-based AI services and on-scanner AI packages are drawn more and more close to the vendor ecosystems to provide automated organ segmentation, tissue quantification and disease-specific reporting templates, which are used to provide standard interpretation and fasten clinical reporting. Helium-free or helium-independent systems have been announced recently by major OEMs and they are reported to be collaborating with infrastructure and compute elements to provide model training and inference at scale - evidence of a trend towards integrating hardware innovations (lighter, more site-friendly magnets) with software value-adds (automated reading, workflow orchestration). This transformation is altering the procurement choices: buyers are enjoying software conduction passes, subscription powered AI qualities, and inventory associations more and more than one time hardware provisions. The trend leaves room to startups around MRI post-processing, foundation models of image synthesis and reconstruction, and tools around clinical domains that can become practices in radiology. Today's commercial environment does not need AI due to the widespread availability of alternative products (Vendor announcements below).<|human|>The commercial landscape of today has no need of AI, as the alternative products are readily available (Vendor announcements below).

•   
•   
  

  Request a Free sample to learn more about this report

    

MAGNETIC RESONANCE IMAGING MARKET SEGMENTATION

By Type

Based on type, the global market can be categorized into 0.2T , 1.5 T, 3.0 T

• 2T: The low-field MRI (approximately 0.2 Tesla) has lower magnetic strength, thereby reducing costs, minimizing shielding/site needs, and allowing lightweight and portability of smaller and smaller clinics or point-of-care centers. Higher fields scanners have a better resolution of the image and a higher signal-to-noise ratio, but current software and AI reconstruction has enhanced the diagnostic utility of the scanners on a wide variety of applications.

• 5T: The global workhorse in the clinical MRI 1.5T systems bring an understanding of flexibility to the clinical indications they clearly serve (neurology, body imaging, cardiac). They are also broadly used outside of hospitals and imaging centers with a huge installed base of coils and proven clinical protocols.

• 0T: The scanners that are 3.0 T are more preferable as they have high signal-to-noise equilibrium and spatial/temporal depth and thus can be employed in sensitive neurological, musculoskeletal and body scanning, which demand fine structure.

By Application

Based on Application, the global market can be categorized into Neurosurgery surgery, Spinal surgery, Orthopedic surgery, Other

• Neurosurgery: In the field of neurosurgery, MRI plays a vital role in preoperative planning, tumor characterization, and intraoperative navigation; specialized (functional MRI, diffusion tensor imaging) protocols map eloquent cortex and white-matter tracts to reduce functional deficit.

• Spinal surgery: Spinal MRI has a comprehensive visualization of the spinal cord involving discs, nerve roots, soft-tissue pathology and spinal cord, which in turn is used in diagnosis and surgical planning in relation to degenerative disease, trauma, infection as well as neoplasm. The multiplanar nature of MRI and contrast sensitivity of the modality allows it to be the modality of choice in order to lower invasive diagnostic procedures when it comes to a number of spinal indications.
• Orthopaedic surgery: MRI is popular in the orthopedic field to assess soft-tissue ligaments, tendons, cartilage, and marrow pathology to aid diagnosis and reinforce reconstructive practice plans and sports injuries. Anatomy of the joints can be viewed well with high resolution coils and special protocols without the use of radiation.

• Other: In addition to surgical application, MRI can be used in cardiology (cardiac MRI to assess function and tissue characterization), oncology (tumor staging and treatment monitoring), and research (functional MRI, MR spectroscopy), and has an increasing number of clinical contracts in the field of interventional MR and the hybrid suite.

MARKET DYNAMICS

Driving Factors

Rising prevalence of chronic and neurological diseases and ageing populations Boost the Market

The key long term magnetic resonance imaging market growth demand drivers are the demographic changes, especially due to ageing various developed markets and increase in incidence of chronic illnesses including cancer, cardiovascular diseases, neurological conditions and so on. Such degenerative spine/ joint disease, neurodegenerative disease and cancer surveillance that are more commonly diagnostic through MRI because of excellent soft-tissue contrast MRI is a critical modality in older populations. Various factors in the middle-income countries where MRI is further encouraged by the expansion of healthcare accessibility, increased screening programs and installations of diagnostic infrastructure. The higher the request rate per capita of MRI across clinicians attempting to detect (in time and more accurately), track treatment response and plan intervention (e.g. MR-guided radiation therapy or neurosurgical planning), the higher the utilization rates per capita. This long-term clinical requirement translates into replacement cycle of installed systems, the purchase varieties of the software in the underserved regions, helps in both sales of hardware and recurrence of revenues on service contracts, software upgrades, and consumables.

Technological innovations: AI, faster acquisition, and helium-free/portable systems Expand the Market

The forces of technology: Technological progress in the MRI market associates: increases in magnet design (free of helium), gradient and coil, and alternative uses of AI-assisted reconstruction and workflow applications are widening the range of MRI applications and other improvements in imaging (scan time, costs, room demands). AI reconstructions and denoising deem short scan plans without diagnostic performance, augmenting throughput and patient content - a viable economic advantage to imaging departments. Ignipro Helium-independent designs are designed to eliminate helium-intensive operation and operational complexity, thus being installed in places where the old large MRI could not exist. Also, the advent of lower-field and more portable MRI groups relocates the modality to the environment of point-of-care and community-based settings. Collectively, the innovations enlarge the pool of buyers, generate the existence of upgrade markets (software and subscriptions) and persuade health care providers to spend in MRI systems that bring more efficient productivity and innovative clinical functionalities.

Restraining Factor

High Capital and Operating Costs Limit Adoption in Resource-Constrained Settings Potentially Impede Market Growth

The major limitation facing PP pipe producers includes price volatility in polypropylene resin and monomer feedstock (propylene) due to the Crude oil/naphtha market fluctuations, plant turnovers, and low-period capacity requirements. Acute rises in the cost of resin push the margins of the manufacturers and may delay projects by not providing them with clients who put off the purchases pending better prices. Supply disruptions, whether through the closure of petrochemical plants, logistical bottlenecks or through the restrictions on exports also compel supply producers to ration material or seek alternative grades, making the long-range planning of production and long-term contracting tricky. Unhedged smaller fabricators with a low hedging strategy or long-term resin deal is especially vulnerable, thus an act of reducing the competition, as well as causing disproportionate regional supply. Although others are addressing this with vertical integration or sourcing diversity, price volatility is still a structural headwind that may slack adoption of price sensitive segments and markets.

Software and AI Services Create High-Margin Recurring Revenue Streams Create Opportunity for The Product in The Market

Opportunity

A significant opportunity is the shift away of mere hardware premiums—which are immediate and toll-based sales adjustments or services—to software-region and subscription-based product divisions: AI and algorithms, cloud processing, image-analysis piping, orchestration of workflows, etc. vendors and third-party developers can thee as a recurring revenue. The Hospitals appreciate options that are throughput-enhancers, report standardization, and also provision of quantitative disease-tracking biomarkers; which are licensed through updates in the software, cloud, and AI packages.

This change will enable the vendors to explore long relationships with clients and provide them with some form of tiered services and the ability to extract value out of the sale, rather than mere sale. In the case of startups and ISVs, the commercialization avenues can be established by placing published AI applications as an element of vendor ecosystems or into the workflows of PACS/RIS.

Regulatory Approval and Clinical Validation of AI-Driven MRI Tools Could Be a Potential Challenge for Consumers

Challenge

With evident performance and workflow advantages, AI, however, is largely sensitive to strict validation and regulation. To authorities AI models to be applied in diagnostic procedures, the regulators (FDA, EMA, among others) demand evidence of safety, reproducibility, and clinical utility of AI models; the procedure may be time-consuming and resources-demanding.

Further on, extrapolating to multiple vendor hardware, different patient groups, and imaging may result in lower performance of models trained on a single dataset to another clinical context, which is achieved by training on a range of datasets and monitoring after clinical deployment. Explainability as well as integration of the solution with the current workflow of PACS/RIS systems, and guarantees regarding data privacy and cybersecurity are also needed by radiologists and IT/security teams in hospitals.

•   
•   
  Request a Free sample to learn more about this report

    

MAGNETIC RESONANCE IMAGING MARKET REGIONAL INSIGHTS

• North America

The largest technologically advanced United States magnetic resonance imaging market is still that of North America, which is characterized by high per-capita utilization with huge installed bases of both 1.5T and 3.0T scanners, well-developed hospital systems, and good reimbursement regimes in most locations that underpin advanced imaging. The clinical needs of high-fidelity diagnostics, research intensity and the high adjustment cycles promote perpetual replacement and upgrading cycles; North America is also a test market and place of launch of new opportunities in the work of the major vendors of the subsidiary category. The infrastructure in the top academic medical centers and clinical trials are increasing the rate of clinical acceptance of new technology like MR-guided therapy and AI tools. Nevertheless, market competition through pricing pressures, mergers between healthcare providers and changes in the reimbursement schedules encourage vendors to manifest evident value (throughput, a diagnostic tool, or cost reductions) to gain an acquisition, making the market attractive as well as competitive.

• Europe

Europe has become a major marketplace with robust healthcare including both the public and the private areas, which are conscious of advanced imaging as well as good investments made in hospital infrastructure within the Western Europe. National purchasing environments (regulatory frameworks (CE marking), local approvals) and national adoption patterns Regulatory controls influence adoption patterns; most European hospitals consider sustainability (energy efficiency, helium free systems) and patient comfort as drivers of their purchases. Cross-border research and clinical partnerships contribute to the dissemination of best practices and speed up the acquisition and use of imaging innovation.

• Asia

With its growing healthcare system, its increasing demand as a middle-up market, and high population of patients in the countries like China, India, and South East Asian Countries, Asia is the fastest-growing MRI market. The factors which drive the growth are the addition of new hospitals, government measures to enhance diagnostic capacity and affordability of imaging services which are on the rise. Although big urban tertiary centers in Asia use high-end 3.0T and high-end workflow, numerous ones focus on the cost quality of 1.5T and low-field as a way to expand access to the field. Competition between local and regional suppliers and the global OEMs is based on prices and service paradigms, finance, managed-service and turnkey solutions are high.

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market Through Innovation and Market Expansion

The MRI market consists of a small number of international OEMs, an ecosystem of software and service providers: Siemens Healthiness, GE HealthCare, Philips Healthcare, and Canon Medical Systems (formerly Toshiba Medical) are the biggest system manufacturers, which offer portfolio of up to 1.5T and 3.0T scanners, service contracts, and are large enterprises investing in AI and workflow solutions. Nothing niche or low-field in some product lines is produced by Hitachi (which fell under Fujifilm ownership) or by a few foreign regional suppliers. Reportedly beyond hardware, reconstruction algorithms, automatic reading software, and quantitative analysis packages (better acquired by up-and-coming startups and even larger external companies such as NVIDIA to accelerate AI) are available as either bundled with scanners or online services. The ecosystem is completed by contract research organizations, third-party service firms and independent coil/accessory makers. The competitive model revolves around competitive providers of the integrated services basis that comprises strong hardware, approved clinical AI, flexible financing, and effective service support providers; successful vendors will be the ones, which will show tangible workflow enhancements, a decrease in overall cost of management, and medically certified value propositions implemented. According to recent announcements made by vendors, their attention centers on helium-free systems, AI-driven scan acceleration, and cloud and ecosystems of partition.

List Of Top Magnetic Resonance Imaging Market Companies

• GE (U.S.)
• Hitachi (Japan)
• Medtronic (Ireland)
• Siemens (Germany)

KEY INDUSTRY DEVELOPMENT

November 2024: Philips unveiled the next-generation BlueSeal helium-free 1.5T MRI system integrated with AI-enabled Smart Reading and automated quantitative reporting at RSNA 2024.

REPORT COVERAGE

With clinical demand, demographic trends, and innovation all taking an upward path, the MRI market is experiencing a steady, technology-driven growth; the age-ing populations and increasing burden of chronic and neurological diseases keeps clinical demand high, and the suppliers of the machines and the software suppliers are driving to expand the accessibility, speed and diagnostic abilities of MRI. Headwinds, which occurred in the short term in afflicted COVID-19 countries, such as postponed procedures, disruptions in the supply chain and interim halts in capital expenditure are to a large extent yielding to a recovery with a greater level of interest in productivity growths, remote workflows and software services being subscriptions. What have the most significant effects are not merely hardware changes to acquire/reconstruct AI-Boolean quicker, no-helium, reduced-field systems that break down geographical limits to sitting, and cloud/AI systems that monetize after-sale and repeat hermits. The developments enlarge the buyer segment (that goes beyond tertiary centers to community hospitals and point-of-care locations), yet creates extra demands: a high level of clinical validation and regulatory approval of the AI tools, the ability to connect with the enterprise imaging systems, as well as cybersecurity and privacy protection. The winners will be the latter who can provide integrated solutions that clearly enhance throughput and results as well as reduce the overall cost of ownership and able to offer flexible financing and effective services networks in the new regions. To innovators, entrants, the option is software, AI and services built over the installed base; to incumbent OEMs it is about the need to switch to offered bundled and outcome-based services as opposed to one-time sold hardware. All in all, MRI is at the center of new age diagnostic medicine - its further development will be dependent on the use of technologies, the various ways of development of reimbursements, as well as the pace of transition of clinical practices to prove AI and quantitative imaging.